In ovarian cancer, we previously reported that expression of N-terminally truncated p73 isoforms has a role in response to platinum-based chemotherapy and constitutes an independent prognostic marker in patients with p53 mutant ovarian cancer (Concin et al, 2005). Here, TP53 is linked to ovarian carcinoma.